ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1657

Do Comorbidities Limit Improvement in Pain and Physical Function After Total Knee Arthroplasty in Patients with Knee Osteoarthritis?

Lauren King1, Esther Waugh1, Allyson Jones2, Deborah Marshall3 and Gillian Hawker4, 1University of Toronto, Toronto, Canada, 2University of Alberta, Edmonton, AB, Canada, 3University of Calgary, Calgary, AB, Canada, 4University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2020

Keywords: Comorbidity, functional status, Osteoarthritis, pain, Total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Individuals with knee osteoarthritis (OA) are increasingly living with multiple comorbid conditions. The presence of comorbidities has been associated with having worse OA symptoms but few studies have assessed their impact on response to OA treatment. We assessed the impact if any of comorbidities on improvement in pain and physical function (patient-reported and performance-based) in recipients of total knee arthroplasty (TKA) for knee OA.

Methods: In the BEST Knee prospective cohort study, patients with knee OA underwent assessment one month prior and 12 months after TKA at two tertiary referral centres in Alberta Canada. Standardized questionnaires assessed sociodemographics social support smoking status self-reported comorbidities and patient-reported outcomes (WOMAC pain, KOOS physical function short-form). Using multivariable generalized-estimating-equation extension of linear regression accounting for potential clustering by surgeon and adjusting for potential confounders we assessed the impact of specific comorbid conditions a priori hypothesized to impact pain and function and total number of conditions reflective of total comorbidity burden separately on change in patient-reported knee pain and physical function at 12 months after TKA. In an exploratory analysis in a subset of patients for whom six-minute walk test (6MWT) a performance-based measure of functional exercise capacity was performed one month prior and 12 months after TKA we assessed the impact of specific and total number of comorbid conditions on change in walking distance.

Results: 1027 participants were included (Table 1) 278 for the 6MWT subset. Mean age was 67 years (SD 8.87) 60% were female 59.3% had a BMI ≥ 30 kg/m2 and 85% reported at least one comorbidity. Individuals with higher number of comorbidities had worse pre-TKA scores for pain physical function and walking distance. At follow-up mean changes in pain function and walking distance were similar for those with and without comorbidities (Table 1). In regression analysis back pain (ß=3.3, 95% CI: 0.6 to 6.1) and cancer (ß=8.4, 95% CI 1.8 to 15.0) were associated with less improvement in patient-reported physical function while depressed mood and a higher total number of conditions were associated with greater improvement in both pain and function. No specific conditions were associated with less improvement in pain. Improvement in walking distance after TKA as measured by the 6MWT was unrelated to specific and total number of conditions (Table 2).

Conclusion: For individuals with knee OA most comorbid conditions do not limit improvement in pain physical function and walking distance (6MWT) after TKA. Understanding response to OA treatment in individuals with comorbidities is important for individualized patient counselling. For patients living with comorbidities these findings are important as improvement in long-term OA outcomes may facilitate better engagement in self-management such as physical activity for their other conditions.


Disclosure: L. King, None; E. Waugh, None; A. Jones, None; D. Marshall, University of Calgary, 2; G. Hawker, University of Toronto, 2.

To cite this abstract in AMA style:

King L, Waugh E, Jones A, Marshall D, Hawker G. Do Comorbidities Limit Improvement in Pain and Physical Function After Total Knee Arthroplasty in Patients with Knee Osteoarthritis? [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/do-comorbidities-limit-improvement-in-pain-and-physical-function-after-total-knee-arthroplasty-in-patients-with-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-comorbidities-limit-improvement-in-pain-and-physical-function-after-total-knee-arthroplasty-in-patients-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology